NCT02752334View on ClinicalTrials.gov

Magnesium Sulphate in the Ultrasound-guided Supraclavicular Brachial Plexus Block

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

February 28, 2019

Study Completion Date

March 31, 2019

Conditions
Pain
Interventions
DRUG

Magnesium Sulphate

Magnesium has antinociceptive effects in animal and human models, principally related to blocking the N-methyl-D-aspartate (NMDA) receptors and regulation of calcium influx into cells.

Trial Locations (1)

112

Tanta University Hospitals, Tanta

All Listed Sponsors
lead

Magrabi Eye & Ear Hospital

OTHER

NCT02752334 - Magnesium Sulphate in the Ultrasound-guided Supraclavicular Brachial Plexus Block | Biotech Hunter | Biotech Hunter